Medtronic's (MDT) new cannula will complement its entire portfolio of balloon kyphoplasty products, including Kyphon Xpander II Inflatable Bone Tamps.

Intragastric balloon beats diet, exercise alone for weight loss Date: November 4, 2014 Source: American Society for Metabolic & Bariatric Surgery (ASMBS) ...

The AMA CPT decision is a positive reflection of the significant clinical evidence supporting the Orbera® Intragastric Balloon, with more than 230 peer-reviewed clinical publications and over ...

Intragastric Balloons Market to Reach $115.3 Million, Globally, by 2033 at 13.6% CAGR: Allied Market Research ...

Intragastric balloons led to superior improvements in obesity-related metabolic risk factors compared with dietary interventions, and were associated with a low rate of adverse events, according ...

Wilmington, Delaware, United States, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global intragastric balloons market is estimated to flourish at a CAGR of 12.2% from ...

Doctors temporarily insert intragastric balloons — medical devices filled with fluid or air — endoscopically in the stomach to help with weight loss along with diet and exercise changes in ...

A study published in the American Journal of Gastroenterology examined intragastric balloons' effectiveness on metabolic outcomes associated with obesity. Researchers analyzed 10 randomized controlled ...

Medtronic plc MDT recently launched a new type of Cannula for balloon kyphoplasty surgeries in the United States. This Kyphon Assist Directional Cannula will be used together with the company’s ...